Advertisement

Topics

Thar Pharmaceuticals plans IPO

15:40 EDT 18 Oct 2016 | Elsevier Business Intelligence

Thar Pharmaceuticals Inc. (reformulates intravenous drugs as oral compounds to improve upon or develop for new indications) filed for an IPO on Nasdaq.

Original Article: Thar Pharmaceuticals plans IPO

NEXT ARTICLE

More From BioPortfolio on "Thar Pharmaceuticals plans IPO"

Quick Search
Advertisement